Oral Contraception

Women's Health Medicine

Volumn 3, Issue 6, 2006, Pages 262-268

  Webberley, Helen ^a   Mann, Melanie ^b  

^a Helen Webberley is a GP in Churchwood Surgery   (United Kingdom)

^b ALEXANDRA HOSPITAL   (United Kingdom)

Author keywords

combined oral contraceptives; contraception; contraceptive pill

Indexed keywords

EID: 34248211185     PISSN: 17441870     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1744-1870(07)70006-9     Document Type: Article

References (13)

1. Anonymous. Oral contraceptives and cardiovascular risk. Drug Ther Bull 38 (2000) 1-5
2. Beral V., Hanaford P., and Kay C. Oral contraceptive use and malignancies of the genital tract. Lancet 2 (1988) 1331-1335
3. British National Formulary. London: BMJ Books. Information available at: http://bnf.org
4. Collaborative Group on Hormonal Factors in Breast Cancer. Breast cancer and hormonal contraceptives: collaborative reanalysis of individual data on 53 297 women with breast cancer and 100 239 women without breast cancer from 54 epidemiological studies. Lancet 347 (1996) 1713-1727
5. Faculty of Family Planning and Reproductive Health Care. Publications, Clinical Guidance. Available at: www.ffprhc.org.uk
6. Faculty of Family Planning and Reproductive Health Care. Publications, Clinical Guidance. In: Glasier A., and Gebbie A. (Eds). Handbook of family planning and reproductive healthcare. 4th ed (2000), Churchill Livingstone, Edinburgh
7. Guillebaud J. Contraception, your questions answered. 4th ed. (2003), Churchill Livingstone, Edinburgh
8. Huber J., Foidart J., Wuttke W., et al. Efficacy and tolerability of a monophasic oral contraceptive containing ethinylestradiol and drospironone. Eur J Contracept Reprod Health Care 5 (2000) 25-34 [Erratum in: Eur J Contracept Reprod Health Care 2001; 6: 63].
9. In: Killick S. (Ed). Contraception in practice (2000), Martin Dunitz, London
10. MacGregor E. Faculty of Family Planning and Reproductive Health Care. Faculty Aid to CPD Topics, Review No. 2001-01: Hormonal Contraception and Migraine (2001), FFPRHC, London
11. Tuckey J. Faculty of Family Planning and Reproductive Health Care. Faculty Aid to CPD Topics, Review No. 2000-04: Combined Oral Contraception and Cancer (2000), FFPRHC, London
12. Vasilakis-Scaramozza C., and Jick H. Risk of venous thromboembolism with cyproterone or levonorgestrel contraceptives. Lancet 358 (2001) 1427-1429
13. WHO Collaborative Study of Neoplasia and Steroid Contraceptives. Invasive squamous cell carcinoma and combined oral contraceptives: results from a multinational study. Int J Cancer 55 (1993) 228-236